Discover the details about Wegovy, a popular weight loss drug now available for telehealth purchase. Understand its benefits, ...

The companies, which have at times had an adversarial relationship, also said they would develop a roadmap to continue their ...

TUCSON, AZ / ACCESS Newswire / April 29, 2025 / Retatrutide, also known as LY3437943, is an innovative triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), ...

Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and ...

The Atlanta-based medical weight loss company has big plans for Tampa Bay, including a large new facility and substantial ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from ...